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Abstract. Protein tyrosine kinase blockers of the tyr- 
phostin family inhibited the EGF-dependent prolifera- 
tion of human and guinea pig keratinocytes grown in 
culture and induced their growth arrest. These blockers 
also significantly inhibited the growth of epidermal 
keratinocytes, but not of dermal cells, in whole skin 
organ culture from both guinea pig and human origin. 
The antiproliferative activity of these tyrphostins cor- 
related quantitatively with their potency as inhibitors 
of EGF receptor autophosphorylation and the EGF- 
dependent protein phosphorylation of intracellular  tar- 
get proteins in the keratinocyte. Furthermore,  no sig- 
nificant cell cytotoxicity or reduction in serine and 
threonine phosphorylation of many intracellular poly- 
peptides were observed upon incubation of the cells 
with tyrphostins like AG213. The complete growth ar- 
rest induced by the tyrphostins is fully reversible and 
upon their removal the keratinocytes resumed their 
growth with the original growth rate.  Because of the 
nontoxic nature of these compounds and their growth- 
arresting  properties,  we suggest their use as agents to 
treat hyperproliferative conditions of human skin. 
p 
HOSPHORYLATION of proteins on tyrosine residues is 
a key biochemical reaction that mediates  a large va- 
riety of cellular signals (14, 32), including the control 
of the cell cycle and cell differentiation.  Many of the cellu- 
lar plasma membrane receptors, such as the receptors for 
EGF, PDGF, and insulin,  possess an integral,  intracellular, 
tyrosine kinase moiety that is activated upon the binding of 
its specific ligand to the extracellular  domain of the receptor 
(28, 32).  The involvement of abnormally high protein tyro- 
sine kinase (PTK)  1 activity with a large variety of growth- 
related  disease states has already been established (5).  In 
many cases, the enhanced PTK activity ofoncogene products 
or the overexpression of their normal counterparts was found 
to be essential  for their transforming  activity  (5, 24, 28). 
Hyperproliferation of cells leading to nonmalignant  growth 
is also often associated with enhanced PTK activity, for ex- 
ample, the enhanced  PTK activity of PDGF receptor which 
results  from its exposure to sustained levels of PDGF seen 
in atherosclerosis and restenosis (24). The overexpression of 
PTK oncoproteins, which results in enhanced kinase activity, 
can also alter the developmental  pattern of cell types into 
which they have been introduced (3,  10, 29). 
The involvement of PTKs in a wide range of disease states 
has thus led to the general concept that development of PTK 
blockers is a reasonable approach to combat hyperprolifera- 
tive conditions which result from enhanced activity of PTKs 
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1. Abbreviation  used in this paper: PTK, protein tyrosine kinase. 
(17, 31). "Tailor-made"  PTK inhibitors  can be used as an- 
tiproliferative  or anticancer agents (17, 31), where each fam- 
ily of  blockers may be useful for a particular set of PTKs. We 
have recently shown that it is indeed feasible to synthesize a 
series of PTK inhibitors  (Tyrphostins)  that can discriminate 
by a factor of over three orders of magnitude  between EGF 
receptor tyrosine kinase and insulin receptor tyrosine kinase 
(11, 31) and with intermediate  potency against p210  ~'-~1 ki- 
nase (Anafi,  M., A.  Gazit,  C. Gilon, Y. Ben-Neriah,  and 
A. Levitzki, manuscript submitted for publication).  These 
EGF  receptor  tyrosine-kinase-directed  inhibitors  block 
EGF-dependent  Ca  2+ signaling and phosphorylation  of phos- 
pholipase C3, (20, 21) as well as EGF dependent proliferation 
of transformed  ceils (18, 31). Furthermore, these studies re- 
vealed a quantitative  correlation between the tyrosine kinase 
inhibitory  potency in vitro and the antiproliferative  activity 
of these tyrphostins on cells (18, 31). 
Among the processes governed by tyrosine kinases is, ap- 
parently,  the normal development of human epidermal ker- 
atinocytes.  These cells, which are capable of developing an 
almost normal differentiation  program in culture (13), have 
been found to be dependent in proliferation on a variety of 
growth-promoting  agents,  in which EGF has a  significant 
role (13, 19, 23, 30).  The closely related TGFot,  which is 
known to bind and activate the EGF receptor (8, 26), was 
also shown to be a potent mitogen of keratinocytes in culture 
(2) and to be actively secreted by keratinocytes in culture, 
and thereby might regulate their normal proliferation in an 
autocrine fashion  (6,  7).  Accumulating  evidence indicates 
that there is an overexpression of the "I'GFot gene in psoriatic 
keratinocytes (9, 27) and accumulation of TGFct  itself in 
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crine activation of the EGF receptor which may play a major 
role in cell hyperproliferation  in human psoriatic epidermis 
(9, 15). 
In  view of  the role  of  EGF receptor  in  the normal human 
keratinocyte  proliferation,  and in its  suggested  possible  in- 
volvement in  abnormal proliferation  typical  of  psoriasis,  we 
were encouraged to examine whether the EGF  receptor- 
directed  Tyrphostins  can be used to specifically  inhibit  the 
EGF receptor-dependent proliferation  of  human and  guinea 
pig keratinocytes  growing in cell  and organ cultures. 
Materials and Methods 
Cell Cultures and Growth Inhibition by ~hostins 
2~yrphostins. Tyrphostins  were synthesized as described by us earlier (11, 
12).  Secondary-  or tertiary-passaged  human keratinocytes  were  seeded 
(5,000-10,000  cells/cm 2) and grown on NIH 3T3  mitomycin-iuactivated 
fibroblasts by the method of Rheinwald and Green (22, 23) (1.2 x  104 cells 
per 35-ram plate),  in 2 mi DME/FI2 (2:1) supplemented with 5% FCS 
(Beit-HaEmek,  Israel) insulin, cholera toxin, hydrocortisone,  transferrin, 
and triiodothyronine (13, 22).  24 h after seeding,  media were replaced by 
new media or containing above tyrphostins at the indicated concentrations 
and 10 ng/ml EGF (mouse submaxillary glands, United States Biochemical 
Corporation, Cleveland, Ohio). Controls with media containing tyrphostins 
but without EGF were run in parallel. Before cell counting the cultures were 
treated with 0.01% trypsin in PBS for 5-10 min at 37°C  to dislodge  the 
feeder layer fibroblasts. Cells were counted in the Coulter Counter at days 
4, 6, and 8 after seeding by treatment of the cultures with trypsin/EDTA/glu- 
cose solution (0.1%, 5 and 10 raM, respectively  in PBS) to suspend the 
cells.  12 h before cell counting,  [3H]thymidine (2 #Ci/ml, specific activity 
80 Ci/mmol, Amersham International, Amersham, UK) was added to a 
portion of the cultures and DNA synthesis was monitored as described (18). 
Data on cell numbers are shown in parallel at day 5.  Each experimental 
point represents the average of triplicate 35-ram plates (Nunc,  Denmark). 
Occasionally, human keratinocytes  were grown in the above medium omit- 
ring the feeder layer for comparison. Guinea pig keratinocytes were isolated 
from young guinea pig ears.  The ears were shaved,  and their upper and 
lower halves were separated by forceps. The cartilage was removed, and the 
skin pieces  (,'°5 mm  2) were incubated 45 rain at 37°C  in PBS with 0.1% 
trypsin (2x  crystallized).  The epidermal cells were obtained by gentle 
scraping of the epidermis from the dermis, in growth medium containing 
5 % newborn calf serum. Guinea pig-derived cells were seeded at high den- 
sity (0.5  x  I06 cells/cm  2) and grown on DME/F12 (2:1 vol/vol) with 10% 
FCS and 10 nM EGF without a 3T3 feeder layer or any other additions. 
Cell proliferation was estimated  as in the case of human keratinocyte cup 
tures omitting  the pretreatment to dislodge  feeder layer cells. 
Inhibition of Cell Growth in Organ Cultures 
Whole normal human foreskin pieces (,,06-7 mm  e) were trimmed from ex- 
cess dermal tissue and were incubated at 37°C,  dermal side down,  in 0.5 
ml culture medium (DME/FI2 as in cell culture) containing 0.25% FCS, 
tyrphostins (50-200/~M), and EGF (10 ng/ml) as indicated.  24-72 h later, 
[3H]thymidine (10 #Ci/mi) was added for another 24 h. At the end of the 
incubation period, the skin pieces were washed three times with PBS con- 
raining 10 mM thymidine (30 mi.n  each) and incubated overnight  with 2.0 M 
NaCI solution containing I0 mM thymidine at 4°(2. Epidermis was then 
separated  easily  from the dermis with a  scalpel.  After washing,  drying 
on filter paper,  and weighing the epidermal and dermal pieces they were 
counted for radioactivity in 4 ml scintillation liquid.  Alternatively,  guinea 
pig organ cultures were prepared from guinea pig ears by preparation of ear 
halves and removal  of excess  dermis and cartilage as above.  Epidermal 
pieces varied in weight from 58 to 156 rag, while a larger variation (100-420 
rag) was encountered in the dermis pieces.  Also, variations were encoun- 
tered in extent of epidermis and dermis labeling from skin to skin. The ex- 
periments were, therefore,  conducted (see Fig. 6 C) so that each foreskin 
was divided into five small pieces which represent a whole experiment (con- 
trol without EGF, control with EGF, and three pieces with EGF and tyr- 
phostins at concentrations of 50, 100, and 200 #M AG213). Results are ex- 
pressed as [3H]thymidine incorporated per mg tissue. 
Permealfflization and In Situ Phosphorylation 
of  Cultured Keratinocytes 
Normal human keratinocytes  were grown in 35-ram culture dishes as de- 
scribed at higher seeds. 3--4 d after seeding (,,°70-80% confluent), the re- 
maining NIH 3"1"3  feeder cells were discarded by careful trypsinization, and 
the cultures were starved for 24 h in regular medium with 0.25% FCS. For 
the phosphorylation reaction, the wells were washed three times with PBS, 
and a reaction mixture containing 75 #g/ml digitonin (crude; Sigma Chemi- 
cal Co., St.  Louis,  MO),  15 #M 7-[32p]ATP (20,000 cpm/pmole; Amer- 
sham International), 1 mM PMSF,  10 #g/mi leupeptin, 20 #g/mi benzami- 
dine, 10 #g/mi soybean-trypsin-inhibitor,  1.0 mM MgCI2, 2.0 mM MnC12, 
20 •M  ZnC12, 2  mM NaVO3, with or without 10 ng/ml EGF,  and tyr- 
phostins, all in 50 mM Hepes,  pH 7.5/saline buffer (600 #l/35-mm dish), 
was added and incubated 5 min in a 37°C bath. The reaction was stopped 
on ice by washing with ice-cold  PBS followed by 15 rain incubation and 
swirling  in 2 mi/dish cold stopping solution containing 1% Triton X-100, 
50 mM Hepes saline, pH 7.5, 10 mM sodium pyrophosphate,  2.0 mM 
NaVO3, 10 mM EDTA, 0.35 mM ATE protease,  and phosphatase inhibi- 
tors as above. Occasionally,  the Triton X-100 extracts and remaining cyto- 
skeletons (removed by rubber policemen from the plates) were analyzed for 
general phosphorylation without immunoprecipitation. 
Immunoprecipitations 
Cells in stopping solution after permeabilization were scraped off with a 
rubber policeman on ice. The lysate was centrifuged for 15 rain in an Ep- 
pendorf centrifuge (14,000 rpm) at 4°C, and the supernatant (containing  the 
triton-extracts and cytosols)  was subjected to immunoprecipitation by in- 
cubating 2 h at 4°C (with continuous rotation 15 rev/min) with monoclonal 
antiphosphotyrosine antibodies coupled to agarose beads via protein A 
(Clone PT-66, a gift of Dr.  Harry Langheheim, Sigma Immunochamicals 
Rehovoth, Israel).  In several assays, the phosphorylation of the EGFR was 
followed by immunoprecipitation with anti-EGFR antibody (mAb 108 ob- 
tained from Rhone Poulenc Rorer Biotechnology, King of Prussia, PA). At 
the end of the incubation, the beads were washed thoroughly with washing 
buffer (same as the stopping solution, but without ATP and Triton X-IO0) 
and treated with SDS-PAGE denaturation buffer.  The denatured reaction 
mixtures were then loaded on 5-15% gradient polyacrylamide  gel and sep- 
arated by electrophoresis (16). After drying of the gels, they were exposed 
to X-ray films (Curix RP-2, Agfa) in cassettes with intensifier screens.  To 
quantitatively estimate the degree of phosphorylation of various protein 
bands, densitometry was performed using a Soft Laser densitometer Model 
SL-TRFF with Videophoresis II program (Biomed Instruments Inc., Fuller- 
ton, CA). The results were presented in arbitrary densitometer units (see 
Figs. 2 and 3) as a percentage of the densitometer units when maximal EGF 
stimulation is 100% value. Occasionally,  the relevant bands were excised 
from the dried gels and counted in scintillation fluid to verify the densito- 
metric analysis.  Good correlation was found between the methods. Immu- 
noprecipitation carried on in the presence of phenyl phosphate (10 mM) 
resulted in almost complete inhibition  of  the precipitation of phosphorylated 
polypeptides.  It thus confirms that >95% of the phosphorylated bands do 
contain tyrosyl  phosphate residues. 
Results 
Tyrphostins were tested for their growth inhibitory potential 
on normal human keratinoeytes in culture grown on mitomy- 
tin-C-treated  31"3 fibroblasts  as feeder layer  (13,  22,  23). 
After 24 h growth in the absence of EGF, EGF and tyrphos- 
tins were added to the cultures and growth resumed for peri- 
ods desired (see Materials and Methods). Tyrphostin-treated 
culture exhibited a strong reduction in cell proliferation rate 
as reflected by cell number,  [3H]thymidine  uptake,  and col- 
ony size.  Fig.  1 shows that the EGF-stimulated growth of 
keratinocytes is inhibited by three tyrphostins  in the micro- 
molar range,  as determined by ceLl number. The ICs0 values 
are reproducible within +  15 % between repetitive experi- 
ments.  Similar inhibition profiles and ICs0 values were ob- 
tained  when  [3H]thymidine  incorporation  was  measured 
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Figure  L  Inhibition of EGF- 
stimulated growth  of human 
keratinocytes grown in culture 
by different tyrphostins. Nor- 
mal human keratinoeytes  were 
grown as described in Mate- 
rials and  Methods.  24  h  af- 
ter seeding, the cultures were 
treated for another 72 h with 
and without EGF and with or 
without four different  tyrphos- 
tins as depicted. Cell growth 
was  monitored  by  counting 
with  the Coulter  counter. Num- 
ber of ceils in wells not con- 
taining EGF were substracted 
from EGF-containing  ones and 
the "EGF-dependent growth" 
was used to plot the tyrphos- 
tin inhibition. 100% EGF-dependent growth are values of cultures without added tyrphostins (1.1 x  10  ~ cells/35-cm  2 plates averaged from 
three separate wells). Each point represents an average of a triplicate where the variation was <10%.  IC50 values varied some 15%  be- 
tween different experiments. 
Figure 2. Inhibition of in situ autophosphorylation of EGF receptor by tyrphostin AG213 (RG 50864). In situ phosphorylation to cultured 
human keratinocytes  was carried out as described in Materials and Methods. Lysates were subjected to immunoprecipitation  using antiphos- 
photyrosine antibodies. Immunoprecipitates were dissolved in SDS-PAGE denaturation buffer,  electrophoresed on polyacrylamide gels, 
and exposed to X-ray films as described in the experimental section. (A) Densitometry values obtained from autoradiogram. (B) Autoradio- 
gram showing the 170-kD EGFR-phosphorylated band. (C) Maximal effect of AG213 (200/~M) compared to control (no EGF) or EGF. 
Quantitation was obtained by densitometry as explained in Materials and Methods and is presented in arbitrary  densitometer units. Maximal 
EGF stimulation was 12,500 densitometer units which represent 1,209 dpm of 32p labeling counted in the acrylamide slice, while control 
(no EGF) was 3,200 densitometric units which represent 288 dpm in the gel slice. 
Dvir et al. Arrest of EGF-dependent Keratinocyte Growth by Tyrphostins  859 Figure 3.  The inhibition of EGF-dependent phosphorylation of intraceUular target proteins. In situ phosphorylation of normal human 
keratinocytes and immunoprecipitations  was carried out as described in Fig. 2 and in Materials and Methods. Various  polypeptides phos- 
phorylated as induced by EGF and inhibited by AG213 (RG 50864) are shown after separation by SDS-PAGE. (A) The inhibition of 
EGF-dependent protein phosphorylation of individual protein bands by tyrphostin AG213 is depicted. The extent of phosphorylation was 
monitored by quantitative densitometry as described in the experimental section. (B) Autoradiogram showing  the various phosphotyrosine 
containing intracellular substrates. 
per cell. In an experiment similar to the one shown in Fig. 
1, the EGF-dependent [3H]thymidine incorporated was re- 
duced from 10  +  1 dprn/cell in the absence of tyrphostins 
to 0.2 +  0.1 dpm/cell in the presence of 100/~M of the vari- 
ous tyrphostins shown in Fig.  1 at 4  d  incubation. At the 
same time, the number of cells was found to be  -4  x  104 
cells in the inhibited cultures and 1.5  x  lO  s cells in unin- 
hibited cultures (average of three plates). Thus, almost com- 
plete  inhibition  of the  EGF-dependent  cell  proliferation 
occurred at high tyrphostin concentrations. Cell death, how- 
ever,  was minimal. After examining cells incubated for 48 
h in the presence of EGF and then for another 4 d with 50, 
100, and 150/~M tyrphostin AG 213  (RG 50864) and ana- 
lyzed for cytotoxic effect (Trypan blue exclusion method), 
only 5  5: 0.6%, 7.5 5:  1.2%, and 12  5: 3% dead cells were 
found, respectively (average of three experiments). In unin- 
hibited cultures only 5-7% dead cells were found after being 
grown for 8 d before trypsinization. Thus, tyrphostins are es- 
sentially cytostatic rather than cytotoxic (see also following 
sections). Tyrphostin AG370, which we have shown earlier 
(12) to be a poor inhibitor of EGFR kinase (12) (IC50 I>820 
#M), is also ineffective in blocking EGF-dependent prolifer- 
ation of keratinocytes (Fig. 1). To address the possible effect 
of the inactivated 3"1"3 fibroblasts present in the cultures as 
"feeder cells" on the extent of inhibition we have grown hu- 
man keratinocytes in the same medium, but without 3T3 
cells added. At these heavy seeds, the cells could be grown 
in the absence of feeder cells (albeit at ,050% reduced rate) 
so we could test for the effect of tyrphostins. The same ICso 
values for tyrphostin AG213 were found in the EGF-depen- 
dent proliferation in the absence of the feeder layer (data not 
shown).  Similar inhibition pattern by tyrphostins was also 
found for guinea pig keratinocyte primary cultures grown in 
the absence of feeder layer (data not shown but see Fig. 5). 
To further investigate the mechanisms of growth inhibition 
by tyrphostins, the effect of tyrphostins on the activity of the 
EGF receptor in these cells was examined. First, we tested 
the effect of these inhibitors on the phosphorylation of the 
receptor itself. Cells were serum starved to enhance EGF re- 
sponsiveness, permeabilized,  and challenged with 3,-p2P]- 
ATP, EGF, and tyrphostins. The EGF receptor was immuno- 
precipitated by antiphosphotyrosine antibodies and analyzed 
by SDS-PAGE. Fig. 2 shows the four- to fivefold increase in 
receptor phosphorylation by EGF and its inhibition  by AG213 
(RG 50864).  This tyrphostin inhibits 80-90 % of EGF acti- 
vation, with an apparent IC50 of 10  +  2 #M, similar to its 
IC50 value on cell growth inhibition (Fig. 1). Receptor phos- 
phorylation in the absence of EGF (basal phosphorylation) 
is always detected and comprises 25-30% of maximal phos- 
phorylation obtained in the presence of EGE Similar results 
were obtained when anti-EGF antibody (mAb 108 obtained 
from Dr.  J.  Schlessinger  [New  York  University Medical 
School and Rhone Poulenc Rorer, King of Prussia, PA] data 
not shown) was used. Also, since no phosphorylated EGF-R 
was detected when the immunoprecipitation with antiphos- 
photyrosine antibody  was  conducted  in  the  presence  of 
10 mM phenyl phosphate (see Materials and Methods), we 
can conclude that tyrphostins inhibit the tyrosine phosphory- 
lation of the receptor. 
We next examined  the effect of  tyrphostin  AG213 (RG50864) 
on the EGF-dependent phosphorylation of intracellular tar- 
get proteins in the serum-starved and permeabilized keratino- 
cytes. Fig. 3 depicts a typical experiment in which the EGF- 
activated phosphorylation of several of intracellular protein 
substrates and its inhibition by AG213 was examined. Most 
of the polypeptides showed a dramatic increase in phosphor- 
ylation (three- to sixfold) in response to EGF, although the 
extent of their "basal" phosphorylation varies. For example, 
The Journal of Cell Biology, Volume  113, 1991  860 Table L Potency of Tyrphostins as Antiproliferative Agents and EGF  Receptor Kinase Blockers 
Phosphorylation of exogenous or 
endogenous substrates 
EGF-receptor 
autophosphorylation IC~o 
ICso,  Purified  Permeabilized 
Tyrphostin  Km  keratinocytes:~  EGFR  keratinocytes 
Cell proliferation ICso 
HER14  Keratinocytes 
/~M  ~uM  /~M  /zM  /~M  /~M 
AG  18  10  +  1"  15  30  +  3*  20  ±  211  15  -t- 2¶  25  +  3** 
AG 213  0.8  +  0.1"  10  8  +  0.9*  10  +  lit  10  ±  1¶  15.0  +  2** 
AG 490  0.6  ±  0.2~  7.0  0.2§  -  3.5§  ±  0.5  7.0  +  1.0"* 
AG 370  >500§  >400  >500§  -  -  - 
* From reL  11. 
¢ Obtained from experiments like the one shown in Fig. 3. 
§ From ref.  12. 
II Obtained in experiments similar to the one shown in Fig. 2. 
¶ From reL  18.  HER 14 cells or N-IH 3T3 cells into which EGF receptor has been stably transfeeted. 
** Experiments performed as in Fig.  1. 
p132, p70, and p61 had a rather high degree of constitutive 
phosphorylation in the absence of EGE  This is in contrast 
to polypeptides like p85,  p33,  and p19,  as well as others, 
which show very low basal phosphorylation  (5%  to  15%) 
in the absence of EGE  The effect of AG213 was very pro- 
nounced, reducing the phosphorylation of most of these pro- 
teins with very similar apparent IC50 values of 10.0 +  3/~M 
(Fig.  3). 
Table I summarizes the parameters of inhibition of the var- 
ious tyrphostins used in different types of biochemical and 
cell growth assays in keratinocytes  (this study) and in the 
HER 14 cells which overexpress EGF receptors and respond 
to the growth factor (18, 20). The inhibition of EGF receptor 
autophosphorylation, phosphorylation of protein substrates, 
and arrest in cell growth by tyrphostins show very similar 
IC50 values. Moreover, the relative potency of the three tyr- 
phostins in the biochemical (both in situ and in vitro) assays 
is identical to their relative potency in inhibiting EGF-depen- 
dent cell growth in two other EGF-responsive cell types (Ta- 
ble I). This correlation substantiates the role of EGF receptor 
in the growth of keratinocytes and that tyrphostin inhibition 
of keratinocyte's growth results from its inhibitory action on 
the tyrosine kinase activity of the EGF receptor. 
To further examine whether tyrosine phosphorylation of 
cellular proteins is inhibited by the drugs used, we tested the 
effect of tyrosine AG213 on total phosphorylation (Fig. 4). 
The EGF-dependent phosphorylation profiles of the Triton 
X-100 extract  and the  cytoskeletons of the permeabilized 
cells  were  analyzed  by  SDS-PAGE  and  autoradiography 
(Fig. 4). Part of the extract was immunoprecipitated by an- 
tiphosphotyrosine and shown for comparison in parallel (see 
Fig. 4, A and B vs C, respectively). As can be seen, tyrosine 
phosphate-containing  polypeptides phosphorylation repre- 
sent a  small  fraction  of the total protein  phosphorylation 
(note days of exposure of autoradiograms  in each fraction 
tested in Fig. 4, A-C, top). Tyrosine phosphate-containing 
polypeptides are barely detectable without prior  immuno- 
precipitation  with antiphosphotyrosine  antibodies because 
of extensive phosphorylation (with the exception of P21 and 
sometimes P17 where EGF-dependent phosphorylation could 
be observed).  Furthermore,  tyrphostins  did not affect the 
overall  serine/threonine  phosphorylation  even at  100 #M, 
pointing again to the specificity and lack of general meta- 
bolic toxicity of these compounds. We have also analyzed the 
effect of AG213 and AG18 on protein kinase C in keratino- 
cyte extracts in vitro. These tyrphostins inhibited PKC activ- 
ity  only  at  millimolar  range  of concentrations  (data  not 
shown). These findings also demonstrate the specific effect 
oftyrphostins on PTKs in these cells. Also, these compounds 
affect cAMP-dependent kinase only close to the mM concen- 
tration  range  (Posner,  I.,  and  A.  Levitzki,  unpublished 
observations). 
We further investigated the effect of the tyrphostins on the 
morphology of keratinocyte cultures to gain insight on the 
mode of tyrphostins action. Arrest of keratinocyte growth by 
tyrphostins is much more pronounced on small, young cell 
colonies where terminal differentiation is still not apparent 
(Fig.  5,  B  and E).  This growth arrest is reversible,  since 
removal of the tyrphostin results in the resumption of ker- 
atinocyte proliferation within 24 h with the same growth rate 
(see rate of thymidine incorporation in the legend to Fig. 5). 
Upon removal of the inhibitors, the "basal" keratinocytes at 
the  proliferative  edge  of the  colony resume  proliferation 
(Figure 5, Cand F), leading to seemingly normal keratiniza- 
tion and differentiation.  Thus, the cells remain viable in the 
presence of tyrphostins in agreement with the low cytotoxic- 
ity values given above. Furthermore,  arrest of keratinocyte 
proliferation by tyrphostins appears not to affect the termi- 
nally differentiated cells in the colonies (Fig.  5, B and E). 
To further examine the possibility that tyrphostins can be 
used as antiproliferative agents in whole skin, we examined 
their effect on epidermal ceils in intact skin cultured in media 
(organ culture). Fig. 6 A shows a representative experiment 
showing that all the tyrphostins tested significantly inhibit 
most of the EGF-dependent  (and some EGF-independent) 
proliferative ability of human epidermal cells in organ cul- 
ture as measured by [3H]thymidine incorporation.  This ex- 
periment represents the best EGF stimulation found in organ 
cultures. Fig. 6 B shows similar results for guinea pig skin. 
To be noted is the similarity in the order of potency of the 
tyrphostins in the different experimental  systems (compare 
to Fig.  1 and Table I). 
To determine  more  quantitatively  the  effect of the  tyr- 
phostins on the proliferation of epidermal and dermal cells 
in  organ  culture,  we conducted  nine  independent  experi- 
ments on human skin in organ culture using three concentra- 
tions of AG 213. Fig. 6 C shows averaged results of six ex- 
periments  where  significant  EGF-dependent  proliferation 
was found. Three conclusions can be drawn from the results. 
(a) Much higher concentrations of AG213 are needed in or- 
Dvir et al. Arrest of EGF-dependent Keratinocyte Growth by Tyrphostins  861 Figure 4.  Effect of EGF and tyrphostins on total and tyrosine phosphate-containing polypeptide phosphorylation. Human keratinocyte 
cultures were grown as in Materials and Methods on 35-mm plates to 90% cortfluency.  The ctdmres were treated as in Figs. 2 and 3 to 
induce in situ pbosphorylation in the presence or absence of 10 ng/ml EGF or 100 ~M AG213 or both (see Materials and Methods). The 
resulting Triton X-100 extracts (cytosols and membrane proteins) were centrifuged 15 min at 10,000 g and either immunoprecipitated with 
antiphosphotyrosine  antibodies or denatured in denaturation buffer for electropboretic separation. The remaining "Triton shells" (cytoskele- 
tons and nuclei) were scraped offthe dishes with a rubber policeman and dissolved in denaturation buffer for SDS-PAGE on 5-15 % gradient 
gels (27 cm long). Equal amounts in "cells equivalents" were loaded onto the gels for comparison. The gels were dried and autoradiographed 
for 1 or 5 d (see above). Note that tyrosyl phosphate-containing polypeptides were barely observed in the general phospborylation  profile 
(with the exception of P21 and P17).  Major tyrosine phosphate-containing polypeptides are marked with open head arrows. These can 
be detected upon further exposure of the gels in C to X-ray film. 
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phostin  AG213 (RG 50864)  on human 
and guinea pig keratinocytes. Human and 
guinea  pig  keratinocyte  cultures  were 
grown  as  described  in  Materials  arid 
Methods,  treated with tyrphostins,  and 
photographed  in  a  phase-contrast  mi- 
croscope  (Olympus  IMT-2  equipped 
with camera). In guinea pig cultures, in- 
cubation times were adjusted somewhat, 
relative to human-derived  cultures.  All 
pictures are shown at 200 ×. (A) Human 
cultures were control photographed  5 d 
after  seeding  cultures  ([3H]thymidine 
incorporation  in  12 h,  31.0 @m/cell). 
(B) Human cultures with 50 #M AG213 
added 2 d after seeding and photographed 
at 5 d. Large colony exhibiting enhanced 
terminal  differentiation is shown.  Cell 
rounding is more prominent in small col- 
onies or single cells (see also Fig. 4 E). 
Fibroblasts of the 3T3 feeder layer seem 
unaffected  (right)  ([3H]thymidine  in- 
corporation,  16.2 dpm/cell). (C) Human 
cultures  incubated with 50 pM AG213 
as above for 24 h only, then washed and 
incubated for another 48 h with regular 
medium; note the extensive outgrowth of proliferating keratinocytes at the edge of the colonies ([3H]thymidine incorporation,  27.6 dpm/ 
cell). (D) Guinea pig keratinocytes control culture photographed after 72 h incubation ([3H]thymidine incorporation,  14.0 dpm/cell).  (E) 
Guinea pig keratinocytes culture with AG213 (50 t~M) added 4 h after seeding, photographed  at 72 h ([3H]thymidine incorporation,  2.0 
@m/cell). (F) Guinea pig keratinocyte culture incubated with 50/~M AG213 as above for 24 h, then washed and incubated further 48 h 
with regular medium ([~H]thymidine incorporation,  12.0 @m/cell). 
gan culture in order to induce '~50% inhibition as compared 
to cell cultures (Fig.  1, Table I):  100 t~M compared to  10 
/~M. (b) There is no tyrphostin inhibition of thymidine incor- 
poration into dermal cells in comparison to the epidermal 
section of the skin and there is no EGF stimulation of [3H]- 
thymidine incorporation into dermal cells.  (c) Tyrphostins 
action in arresting growth of epidermal keratinocytes is not 
confined to normal human cells, but is also evident in guinea 
pig-derived epidermal keratinocytes, where similar results 
have been obtained (Figs. 5 F and 6 B). As mentioned above, 
in contrast to human keratinocytes that grow on irradiated 
NIH 3T3 feeder layer cells, guinea pig keratinocytes do not 
require the feeder layer for their growth in culture. 
Figure 6. Inhibition of EGF-stimulated growth by tyrphostins in organ cultures. Organ Culture of  human (A) and guinea pig (B) skin pieces 
was performed as described in Materials and Methods. Growth stimulation by EGF and its inhibition by three different tyrphostins is shown. 
(A) Human skin incubated 72 h with  100 ttM of various tyrphostins  in the presence of 10 ng EGE One experiment of three is shown. 
(B) Guinea pig ear skin incubated with  10 nM EGF and  100 #M tyrphostins  as in A. One experiment of three is shown. (C) Human 
skin incubated with 50,  100, and 200/~M AG213 for 48 h in the presence of 10 nM EGF, where the last 24 h were in the presence of 
[3H]thymidine. The values are presented as an average of six independent experiments.  100% value (516-769 dpm/mg in the epidermis 
and 221-535 in the dermis) represents  [3H]thymidine incorporation  in the absence of EGF. Stimulation by EGF varied between  12 and 
43%  above controls without EGF in various samples. 
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Protein  tyrosine  phosphorylation  comprises  a  very  small 
portion  of total  phosphorylation  of cellular  proteins  (14). 
Nevertheless,  tyrosine phosphorylation plays a key role in 
signal transduction,  resulting  in cell growth.  In numerous 
cases, hyperproliferation as well as cell transformation is as- 
sociated with the enhanced activity of protein tyrosine ki- 
nases (5, 28, 29, 32). We have, therefore, reasoned that de- 
veloping specific tyrosine kinase inhibitors could be of use 
in suppressing states of hyperproliferation and malignancy 
(17, 31). 
Indeed, we could demonstrate that protein tyrosine kinase 
blockers  from the tyrphostin  family effectively inhibit the 
EGF-dependent proliferation of tissue culture cells that ex- 
press EGF receptors.  Furthermore,  we found that their an- 
tiproliferative activity correlates well with their potency to 
inhibit  EGF  receptor  kinase  activity  (12,  18,  31).  In this 
study we show for the first time the inhibitory effect of tyr- 
phostins on cultured normal keratinocytes (Figs.  1 and 5), 
and  that  the  antiproliferative  activities  of the  tyrphostins 
correlates very well with their potency to inhibit the EGF- 
dependent phosphorylation of the EGF receptor and of intra- 
cellular substrates (Figs. 2 and 3). This conclusion is further 
strengthened by the finding that the overall serine/threonine 
phosphorylation  was  not affected significantly  by the tyr- 
phostins used (Fig. 4) and that other important signal trans- 
ducting systems, protein kinase C and cAMP-dependent pro- 
tein kinase,  were not inhibited by concentrations up to the 
millimolar range (data not shown). Furthermore, the inhibi- 
tory effects of these blockers is exerted directly on the ker- 
atinocytes without the mediation of the feeder layer cells (see 
Results). 
From Fig.  6, which depicts the effect of the blockers on 
human and on guinea pig keratinocytes in organ culture, it 
is apparent that tyrphostins inhibit both EGF-dependent and 
EGF-independent  growth.  This  phenomenon  is  also  ob- 
served, though to a lesser extent,  for human keratinocytes 
grown in cell culture. These seemingly puzzling findings can 
be accounted for by two alternative possibilities. (a) The in- 
hibition by tyrphostins involves other type(s) of tyrosine ki- 
nase(s).  (b) The so called EGF-independent portion of cell 
growth is mainly mediated via the action of auto-secreted 
TGFot (6, 7), and therefore also involves the EGF receptor 
(15). 
One can argue that  in  organ  culture  the "mesenchymal 
effect" (13)  of the dermal  portion  in  the  skin may induce 
EGF-independent growth of the keratinocytes. However, our 
ability to demonstrate  similar tyrphostin inhibition  in cul- 
tures without feeder layer and in guinea pig keratinocytes 
grown regularly without any feeder cells again shows that the 
keratinocyte alone can grow in an "EGF-independent" fash- 
ion, at least partially. Furthermore, EGF dependency also is 
not complete in keratinocyte cultures grown in different me- 
dia too without feeder layers (19, 30, and this study). 
The quantitative correlation between inhibition of EGF-de- 
pendent growth (Fig. 1), EGF-dependent receptor autophos- 
phorylation (Fig. 2), and EGF-dependent tyrosine phosphor- 
ylation of intracellular substrates (Fig. 3) clearly implicates 
the EGF receptor in mediating the inhibitory effects of the 
above blockers, and strongly favors the second possibility. In 
permeabilized keratinocytes 80-95 % of the apparent tyro- 
sine phosphorylation  observed is EGF dependent (Figs.  3 
and 4), yet the tyrphostin's ICs0 values for inhibition of phos- 
phorylation are identical  to their ICs0 values observed for 
inhibition of cell growth and for the inhibition EGF receptor 
autophosphorylation  (Fig.  2). 
It seems, therefore, that the basal activity of the receptor 
might reflects autocrine activation by TGFo~, which was re- 
ported to be produced in these cells (6, 7) and therefore most 
of EGF-independent growth signal seems to reflect TGFt~- 
stimulated EGF receptor.  Should this be the case, it could 
be postulated that the reduction of the EGF-independent sig- 
nals  as  obtained  in  the  "in  situ"  phosphorylation  assays, 
stems from the washing of secreted TGFet present in the cul- 
ture medium before the experiment.  This possibility is also 
supported by the observation that anti-EGF antibodies (capa- 
ble of cross-reactivity with TGFa molecules) inhibited some 
30% of the EGF-independent portion of cell growth (data not 
shown). Furthermore,  preliminary  studies using 32p-labeled 
cells followed by EGF-R immunoprecipitation  showed high 
basal phosphorylation  of EGF-R in the absence of added 
EGF in unstarved  keratinocyte cultures  (our unpublished 
data), thus, supporting the assertion that some EGF-R mole- 
cules are "autoactivated" by the putative autosecreted TGFc¢. 
The arrest of keratinocyte growth by the PTK blocker tyr- 
phostin AG213 (RG50864) is reversible and affects the pro- 
liferating  keratinocytes  (Fig.  5).  This  reversible action of 
tyrphostins AG213, and also of AG18 and AG490 (data not 
shown), and their nontoxicity (see Results) was also observed 
in EGF-dependent growth of other cultured cells harboring 
the EGF receptor and whose growth is strongly stimulated 
by EGF (11, 12,  18, 31). 
From Fig.  1 it is apparent that the inhibitory IC50 values 
for the three tyrphostins examined are in the range of 7-25 
/~M, whereas the Ki values of these compounds are an order 
of magnitude lower (11, 12, 31).  The higher concentrations 
required for the inhibition of EGF-dependent cell growth as 
compared to the activity of these compounds in vitro most 
probably reflects the presence of high affinity intracellular 
substrates which compete effectively with the tyrphostin. We 
have already  observed previously that AG213  inhibits  the 
EGF-dependent  phosphorylation  of PLC'y  at  rather  high 
concentrations,  probably because of the protein's  tight as- 
sociation with the EGF receptor (20, 21). 
We are currently  attempting  to design more potent tyr- 
phostins and hydrophobic derivatives of these blockers in or- 
der to obtain compounds that are more active in intact cells. 
We have recently been able to demonstrate that a hydropho- 
bic PDGF receptor kinase blocker AG17 (RG 50872) is a 
much more effective blocker of PDGF-dependent tyrosine 
kinase in intact rabbit vascular smooth muscle cells than a 
PDGF receptor kinase blocker in cell-free systems. Further- 
more,  the PDGF receptor kinase blocking activity in situ 
correlates quantitatively  with  its ability to inhibit  PDGF- 
induced cell proliferation  (4). In contrast,  nonhydrophobic 
tyrphostins exhibit similar or higher  inhibitory IC50 values 
as blockers of PDGF-stimulated  cell growth as compared 
with their inhibitory activity in vitro (4). We also observed 
previously that hydrophobic insulin receptor kinase blockers 
are more effective in intact cells than in vitro (25; Zik, Y., 
and A.  Levitzki, unpublished results). 
Our findings that tyrphostins arrest the growth of human 
keratinocytes, but do not possess large and significant toxic 
The Journal of Cell Biology, Volume  113, 1991  864 adverse effects on the cells up to 200/zM or higher (Figs. 
4  and 5),  make them strong candidates as agents against 
hyperproliferation of keratinocytes, which occurs  in  skin 
disorders such as psoriasis. 
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Y.  Milner). 
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